UPDATE: Jefferies Upgrades Milestone Pharmaceuticals (MIST) to Buy
Tweet Send to a Friend
(Updated - July 24, 2020 5:06 AM EDT)
(updating comment)Jefferies analyst Chris Howerton upgraded Milestone Pharmaceuticals (NASDAQ: MIST) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Jefferies analyst Chris Howerton upgraded Milestone Pharmaceuticals (NASDAQ: MIST) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
